Brimonidine purite solution for open-angle glaucoma or ocular hypertension

被引：0

作者：

Batiste, Corey G. ^{[2
,3
]}

Myers, Jonathan ^{[2
,3
]}

Katz, L. Jay ^{[1
,3
]}

机构：

[1] Wills Eye Hosp & Res Inst, Glaucoma Serv, Philadelphia, PA 19107 USA

[2] Wills Eye Hosp & Res Inst, Philadelphia, PA 19107 USA

[3] Thomas Jefferson Med Univ, Philadelphia, PA 19107 USA

来源：

EXPERT REVIEW OF OPHTHALMOLOGY | 2008年 / 3卷 / 05期

关键词：

brimonidine purite; ocular hypertension; open-angle glaucoma;

D O I：

10.1586/17469899.3.5.513

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

Brimonidine (0.1 and 0.15%) tartrate used with the preservative purite has been shown to be as efficacious as brimonidine 0.2% tartrate in lowering intraocular pressure in clinical trials. The purite preservative has proven to be better tolerated and less toxic in brimonidine solution than the original preservative benzalkonium chloride. In addition, the lower concentrations of active drug appear to offer safer adverse event profiles than the original formulation, while maintaining its efficacy.

引用

页码：513 / 515

页数：3

共 50 条

[21] Brimonidine purite and bimatoprost compared with timolol and latanoprost in patients with glaucoma and ocular hypertension
Netland, PA
Mroz, M
Rosner, SA
Katzman, B
Macy, JI
ADVANCES IN THERAPY, 2003, 20 (01) : 20 - 30
[22] Brimonidine Purite and bimatoprost compared with timolol and latanoprost in patients with glaucoma and ocular hypertension
Peter A. Netland
Michael Mroz
Sarah A. Rosner
Barry Katzman
Jonathan I. Macy
Advances in Therapy, 2003, 20 : 20 - 30
[23] Clinical effectiveness of brinzolamide 1%-brimonidine 0.2% fixed combination for primary open-angle glaucoma and ocular hypertension
Sharma, Sourabh
Trikha, Sameer
Perera, Shamira A.
Aung, Tin
CLINICAL OPHTHALMOLOGY, 2015, 9 : 2201 - 2207
[24] Latanoprostene Bunod Ophthalmic Solution 0.024%: A Review in Open-Angle Glaucoma and Ocular Hypertension
Hoy, Sheridan M.
DRUGS, 2018, 78 (07) : 773 - 780
[25] Netarsudil ophthalmic solution 0.02% for the treatment of patients with open-angle glaucoma or ocular hypertension
Kopczynski, C. C.
Heah, T.
DRUGS OF TODAY, 2018, 54 (08) : 467 - 478
[26] Latanoprostene Bunod Ophthalmic Solution 0.024%: A Review in Open-Angle Glaucoma and Ocular Hypertension
Sheridan M. Hoy
Drugs, 2018, 78 : 773 - 780
[27] MICROCIRCULATION AND HEMODYNAMICS IN OCULAR HYPERTENSION AND PRIMARY OPEN-ANGLE GLAUCOMA
ALEXEEV, BN
SHMYREVA, VF
MOSTOVOI, EN
VESTNIK OFTALMOLOGII, 1986, (05) : 8 - 10
[28] Prostaglandin Intracameral Implants for Ocular Hypertension and Open-Angle Glaucoma
Cheng, Christine M.
Rehmani, Cameron
Chin, Jordan
JOURNAL OF PHARMACY TECHNOLOGY, 2025,
[29] Efficacy of brimonidine purite 0.5% compared with timolol 0.5% in patients with glaucoma and ocular hypertension
Mundorf, TK
Dirks, M
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2005, 46
[30] Color Doppler imaging in ocular hypertension and open-angle glaucoma
Akarsu, C
Bilgili, MYK
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2004, 242 (02) : 125 - 129

← 1 2 3 4 5 →